James Topper - Sep 22, 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Director, 10%+ Owner
Signature
/s/ Larry Miller, Attorney-in-Fact for James Topper
Stock symbol
PHAT
Transactions as of
Sep 22, 2022
Transactions value $
$0
Form type
4
Date filed
9/26/2022, 04:09 PM
Previous filing
Feb 14, 2022
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy Award $0 +20K $0.00 20K Sep 22, 2022 Common Stock 20K $10.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to one-third of the shares of common stock on September 22, 2023, and will vest with respect to the remaining shares in equal monthly installments over the following two years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.